S-90-3321

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameS-90-3321
Drug Alias NameS-90-3321
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibrinogen antagonistsIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3Fibrinogen
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst AG
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A